Novacyt S.A.

NCYT.L·LSE
Compare
39.05−0.25 (−0.64%)today
At close: Oct 22, 4:00 PM BST · May be delayed up to 15 min · GBX

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close39.30
Open0.00
Day range0.0039.05
52-week range0.0086.00
Off day high0.00%
Off 52-week high−54.59%
Volume4.00
Avg. volume (3M)85.77K
Market cap28.32M
EPS (TTM)-0.3100
Forward P/E-5.61
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding72.52M
Short interest—
Earnings dateApr 30, 2025
Analyst target—
Profit margin—

Against its peers

Compare in full ›
NCYT.L TRIB QTI VNRX ALERS.PA BMRA
Market cap 28.32M 5.94M 32.93M 5.23M 253.72M 7.73M
P/E (TTM) — — — — 36.0 —
Forward P/E -5.6 -7.1 -15.0 -0.2 22.3 4.3
Price/book 1.5 -0.1 13.8 -0.1 1.3 2.1
Dividend yield — — — — — —
1-year change −4.84% −76.14% −63.65% −98.07% +3.49% −43.24%
Today −0.64% −2.81% −4.46% +2.96% 0.00% 0.00%

The closest companies by business and industry (Medical Devices). Prices may be delayed up to 15 min.

Latest news

All NCYT.L news ›
MarketScreener·Positive

Novacyt's strikes Illumina deal; Beeks' Thailand deal

The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: ---------- Novacyt SA - biotechnology group focused on clinical... Biotechnology & Medical Research…

From articles in the 4Search news index.

In the news

5mentions in 30 days
5with it in the headline
Positivesentiment

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 5 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.